Skip to content
OpenCapital
Collapse sidebar
Watchlist
Screener
Filings
Earnings
Charts
Collapse sidebar
Screener
Stocks
Recursion Pharmaceuticals, Inc.
Business Segments
Business Segments
Business Segments
13 metrics
Revenue from Contract with Customer, Excluding Assessed Tax
Salaries
Consumables
Platform
Discovery
Clinical development
D&A
Other segment items
Operating Income (Loss)
Other income (loss), net
Income Tax Expense (Benefit)
Net loss
Total expenditures for additions to long-lived assets
Watchlist
Screener
Filings
Earnings
Charts